Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
VCYT	VERACYTE INC	$2.61B	5.30%	4.90%	5.07%	34.00%	0.07	8.15	70.10%	12.80%	13.19%
PHAR	PHARMING GROUP NV	$1.10B	1.10%	0.60%	3.43%	5.40%	0.80	2.59	87.90%	0.80%	3.50%
JAZZ	JAZZ PHARMACEUTICALS PLC	$11.64B	-8.80%	-3.10%	-4.60%	-6.20%	1.70	1.86	88.20%	-8.30%	-10.16%
INVA	INNOVIVA INC	$1.67B	30.60%	19.20%	21.67%	35.20%	0.39	14.64	74.80%	65.90%	83.52%
AUPH	AURINIA PHARMACEUTICALS INC	$1.91B	70.40%	50.20%	18.01%	23.80%	0.29	5.25	88.50%	101.50%	41.86%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.36B	-76.50%	55.60%	108.86%	39.00%	-5.32	2.06	97.80%	30.20%	39.58%
PBYI	PUMA BIOTECHNOLOGY INC	$322.05M	27.80%	15.40%	31.40%	62.00%	0.66	2.00	74.50%	13.60%	18.57%
EXEL	EXELIXIS INC	$11.11B	36.90%	28.00%	38.59%	42.20%	0.32	3.56	96.40%	33.70%	40.57%
ASMB	ASSEMBLY BIOSCIENCES INC	$454.78M	-5.60%	-3.60%	-2.93%	-6.70%	0.25	5.22	N/A	N/A	N/A
XERS	XERIS BIOPHARMA HOLDINGS INC	$913.89M	-5.30%	0.20%	10.82%	9.50%	27.02	2.19	85.40%	0.20%	10.16%
TBPH	THERAVANCE BIOPHARMA INC	$787.33M	46.00%	25.40%	29.45%	55.30%	0.64	10.93	100.00%	98.50%	122.56%
ANAB	ANAPTYSBIO INC	$1.88B	N/A	-3.60%	-4.01%	-2.40%	8.79	9.07	100.00%	-5.60%	-5.57%
RPRX	ROYALTY PHARMA PLC	$27.13B	8.00%	4.10%	5.68%	4.40%	1.02	2.40	100.00%	32.40%	45.35%
MDXG	MIMEDX GROUP INC	$609.12M	21.20%	15.90%	22.75%	60.00%	0.34	4.32	82.60%	11.60%	15.13%
VRTX	VERTEX PHARMACEUTICALS INC	$115.58B	22.70%	16.20%	21.38%	29.90%	0.37	2.90	86.20%	32.90%	38.80%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$2.82B	-10.30%	-4.30%	-0.95%	-0.90%	1.29	3.17	90.20%	-4.30%	-0.77%
VCEL	VERICEL CORP	$1.60B	5.20%	3.70%	4.10%	4.40%	0.38	5.03	74.40%	6.00%	6.52%
CGEN	COMPUGEN LTD	$194.78M	55.70%	29.70%	26.42%	197.10%	0.52	6.56	87.30%	48.60%	48.65%
ONC	BEONE MEDICINES LTD	$31.48B	7.30%	4.10%	7.47%	16.70%	0.88	3.41	87.50%	5.40%	8.89%
SLGL	SOL-GEL TECHNOLOGIES LTD	$220.30M	-23.70%	-18.60%	-25.80%	-47.00%	0.31	4.37	100.00%	-31.60%	-31.60%
LCTX	LINEAGE CELL THERAPEUTICS INC	$386.09M	-131.00%	-62.80%	-67.99%	-1,983.10%	1.55	5.20	99.00%	-436.50%	-472.75%
TVTX	TRAVERE THERAPEUTICS INC	$2.54B	-40.20%	-4.50%	-3.10%	-2.40%	4.27	2.74	97.90%	-5.20%	-2.81%
ADMA	ADMA BIOLOGICS INC	$2.29B	35.00%	26.00%	34.21%	38.40%	0.31	6.71	57.40%	28.80%	37.20%
STTK	SHATTUCK LABS INC	$455.86M	-65.00%	-58.60%	-58.12%	-181.80%	0.11	11.70	100.00%	-4,880.90%	-4,880.90%
XLO	XILIO THERAPEUTICS INC	$49.32M	-311.80%	-26.60%	-35.60%	119.70%	3.39	2.58	100.00%	-80.10%	-80.05%
INCY	INCYTE CORP	$18.36B	29.10%	20.70%	30.63%	77.30%	0.35	3.32	92.80%	25.00%	32.42%
LQDA	LIQUIDIA CORP	$3.23B	-209.30%	-25.30%	-23.29%	-24.60%	6.33	2.01	91.60%	-43.50%	-28.27%
CPRX	CATALYST PHARMACEUTICALS INC	$2.91B	24.30%	21.20%	29.63%	308.40%	0.16	6.08	85.20%	36.40%	48.14%
FENC	FENNEC PHARMACEUTICALS INC	$173.48M	N/A	-15.00%	-9.73%	-11.40%	-11.97	4.69	93.10%	-17.90%	-9.89%
NAGE	NIAGEN BIOSCIENCE INC	$361.96M	26.10%	18.40%	21.03%	138.30%	0.39	4.86	64.30%	13.40%	14.06%
FBIO	FORTRESS BIOTECH INC	$92.80M	-14.70%	-3.20%	11.79%	23.20%	2.08	2.19	71.60%	-8.60%	24.09%
AGEN	AGENUS INC	$136.70M	N/A	0.00%	-57.28%	-318.60%	-1.86	0.41	99.10%	-0.10%	48.50%
SLNO	SOLENO THERAPEUTICS INC	$1.64B	5.80%	4.50%	5.25%	7.60%	0.25	5.80	98.60%	10.80%	13.85%
TARS	TARSUS PHARMACEUTICALS INC	$2.85B	-19.60%	-12.70%	-13.00%	-16.40%	0.64	3.85	93.20%	-14.70%	-12.28%
ALNY	ALNYLAM PHARMACEUTICALS INC	$43.59B	90.30%	6.70%	16.45%	11.30%	5.29	2.76	81.60%	8.40%	15.50%
RIGL	RIGEL PHARMACEUTICALS INC	$485.66M	240.80%	128.90%	31.17%	70.00%	0.31	2.42	93.30%	124.70%	43.89%
XOMA	XOMA ROYALTY CORP	$359.55M	22.50%	7.60%	13.31%	14.80%	2.01	3.37	100.00%	35.50%	60.69%
IBRX	IMMUNITYBIO INC	$8.30B	N/A	-81.40%	-54.30%	-21.40%	-2.00	5.10	99.30%	-310.20%	-210.97%
ENTA	ENANTA PHARMACEUTICALS INC	$353.17M	-78.60%	-23.20%	-22.46%	-23.10%	1.60	4.44	100.00%	-106.80%	-95.48%
ZVRA	ZEVRA THERAPEUTICS INC	$536.04M	74.60%	33.80%	38.56%	47.10%	0.84	5.68	84.50%	78.20%	88.90%
SPRO	SPERO THERAPEUTICS INC	$135.78M	-125.90%	-57.60%	-107.47%	-555.50%	1.05	3.83	100.00%	-108.10%	-107.39%
REGN	REGENERON PHARMACEUTICALS INC	$79.23B	14.80%	11.50%	14.57%	15.60%	0.30	4.13	85.40%	31.40%	36.77%
NBP	NOVABRIDGE BIOSCIENCES	$304.52M	-11.50%	-10.80%	-9.39%	-26.90%	0.07	14.47	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$79.69M	N/A	-283.50%	178.92%	110.80%	-1.81	0.31	58.80%	-2,336.50%	-2,281.71%
VIR	VIR BIOTECHNOLOGY INC	$1.25B	-49.30%	-38.70%	-48.11%	-53.00%	0.31	5.54	100.00%	-638.90%	-638.56%
HALO	HALOZYME THERAPEUTICS INC	$7.46B	92.70%	14.10%	20.65%	20.10%	50.73	4.66	83.60%	22.70%	34.73%
ADCT	ADC THERAPEUTICS SA	$504.37M	N/A	-47.30%	-35.57%	-77.00%	-2.74	4.37	92.90%	-175.30%	-110.59%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$3.51B	11.50%	8.60%	14.23%	23.00%	0.35	3.79	88.50%	8.70%	13.12%
BMRN	BIOMARIN PHARMACEUTICAL INC	$10.69B	5.80%	4.70%	7.22%	8.70%	0.25	5.21	77.70%	10.80%	15.32%
EVAX	EVAXION A	$30.86M	-100.20%	-37.70%	-19.12%	-44.60%	0.67	5.85	100.00%	-102.40%	-61.34%
TECH	BIO-TECHNE CORP	$8.24B	4.10%	3.20%	5.15%	9.40%	0.25	4.54	65.20%	6.70%	10.09%
LGND	LIGAND PHARMACEUTICALS INC	$4.08B	13.90%	10.20%	10.75%	17.20%	0.53	22.23	94.60%	46.40%	61.05%
NBTX	NANOBIOTIX SA	$1.48B	N/A	-78.30%	217.34%	-442.80%	-1.66	0.63	100.00%	-508.40%	-382.20%
QTTB	Q32 BIO INC	$106.06M	1,630.20%	45.10%	59.13%	188.90%	0.47	4.85	100.00%	55.50%	55.49%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$2.18B	-30.00%	-11.80%	-11.29%	-10.60%	1.32	3.34	74.20%	-21.50%	-17.23%
KRYS	KRYSTAL BIOTECH INC	$7.45B	18.70%	17.10%	15.39%	26.00%	0.09	9.95	94.10%	52.60%	48.69%
ORMP	ORAMED PHARMACEUTICALS INC	$139.31M	27.20%	25.60%	20.05%	36.60%	0.09	22.25	0.60%	2,192.60%	2,149.00%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$66.85M	10.60%	8.40%	6.37%	36.60%	0.06	35.56	N/A	N/A	N/A
ASND	ASCENDIS PHARMA A	$13.56B	N/A	-19.80%	-2.56%	-0.90%	-9.00	1.04	86.80%	-31.70%	-0.83%
DTIL	PRECISION BIOSCIENCES INC	$159.98M	-95.10%	-38.00%	-30.45%	-116.40%	0.67	13.32	100.00%	-133.40%	-129.30%
ABUS	ARBUTUS BIOPHARMA CORP	$885.52M	-42.40%	-32.50%	-37.70%	-47.50%	0.24	15.73	100.00%	-237.90%	-237.19%
ARGX	ARGENX SE	$43.14B	20.20%	17.40%	17.42%	34.00%	0.19	5.23	N/A	N/A	N/A
AXSM	AXSOME THERAPEUTICS INC	$8.28B	-254.10%	-28.20%	-56.97%	-108.20%	6.81	1.56	92.60%	-28.70%	-27.74%
MRNA	MODERNA INC	$21.15B	-30.10%	-22.90%	-26.74%	-28.30%	0.43	3.29	55.30%	-145.20%	-142.39%
UTHR	UNITED THERAPEUTICS CORP	$23.74B	19.30%	17.30%	23.68%	31.70%	0.11	6.61	87.90%	41.90%	54.46%
ACAD	ACADIA PHARMACEUTICALS INC	$3.75B	41.90%	29.80%	10.79%	20.10%	0.27	3.83	91.70%	36.50%	12.96%
ALMS	ALUMIS INC	$3.16B	-72.60%	-54.90%	-74.39%	-96.50%	0.37	4.34	100.00%	-1,011.70%	-1,047.34%
MIRM	MIRUM PHARMACEUTICALS INC	$5.44B	-8.50%	-3.10%	-1.10%	-1.70%	1.68	2.67	80.80%	-4.50%	-1.35%
KZIA	KAZIA THERAPEUTICS LTD	$413.76M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
DOMH	DOMINARI HOLDINGS INC	$50.60M	116.20%	102.20%	51.12%	114.70%	0.06	27.54	100.00%	110.90%	110.86%
SLN	SILENCE THERAPEUTICS PLC	$258.11M	N/A	-56.40%	-75.19%	-110.30%	-1.11	8.72	61.50%	-15,851.90%	-15,849.91%
RLAY	RELAY THERAPEUTICS INC	$1.72B	-43.20%	-39.20%	-46.41%	-45.20%	0.10	22.61	100.00%	-1,800.60%	-1,800.58%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.60B	19.80%	13.70%	22.53%	55.20%	0.46	3.60	77.20%	18.30%	26.45%
RCUS	ARCUS BIOSCIENCES INC	$2.69B	-65.80%	-32.50%	-38.00%	-47.30%	0.81	4.36	100.00%	-142.90%	-139.68%
PLYX	POLARYX THERAPEUTICS INC	$297.32M	-193.70%	-176.70%	-196.82%	3,689.90%	0.13	8.55	N/A	N/A	N/A
NRXS	NEURAXIS INC	$84.02M	-338.00%	-154.50%	-213.92%	690.70%	0.88	2.05	84.20%	-241.40%	-216.47%
INSM	INSMED INC	$31.97B	-168.40%	-57.30%	-66.16%	-62.30%	2.06	3.83	79.70%	-210.50%	-195.90%
IVVD	INVIVYD INC	$440.85M	-48.70%	-34.50%	-21.63%	-414.90%	0.15	7.24	93.00%	-98.20%	-98.25%
TSHA	TAYSHA GENE THERAPIES INC	$1.32B	-56.60%	-38.50%	-34.39%	-194.10%	0.39	12.23	100.00%	-1,115.30%	-1,114.62%
BEAM	BEAM THERAPEUTICS INC	$2.35B	-7.30%	-5.70%	-5.78%	-7.50%	0.20	13.09	100.00%	-57.20%	-57.24%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$8.51B	36.10%	13.60%	24.97%	17.70%	1.83	3.38	100.00%	18.50%	28.77%
SEPN	SEPTERNA INC	$1.09B	-12.60%	-9.50%	-9.60%	-17.50%	0.56	4.73	100.00%	-106.40%	-106.35%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$799.48M	-51.10%	-17.00%	-33.14%	-18.50%	1.87	6.60	18.30%	-70.40%	-58.14%
ADAG	ADAGENE INC	$191.82M	-63.30%	-35.70%	-76.75%	184.60%	0.76	2.29	100.00%	-28,961.70%	-28,260.68%
PTGX	PROTAGONIST THERAPEUTICS INC	$6.66B	-19.90%	-18.40%	-20.76%	-23.90%	0.09	12.71	100.00%	-282.80%	-281.01%
KALV	KALVISTA PHARMACEUTICALS INC	$866.36M	N/A	N/A	N/A	N/A	19.00	7.22	N/A	N/A	N/A
ANL	ADLAI NORTYE LTD	$262.47M	-139.00%	-47.40%	-499.85%	552.50%	8.10	1.03	N/A	N/A	N/A
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$267.44M	-185.10%	-65.90%	-52.54%	-87.70%	0.96	6.45	99.40%	-158.20%	-153.97%
VRCA	VERRICA PHARMACEUTICALS INC	$79.37M	N/A	-42.30%	-33.05%	-46.20%	0.91	2.59	90.30%	-50.30%	-28.51%
LEGN	LEGEND BIOTECH CORP	$3.26B	-29.20%	-17.60%	-23.80%	-36.80%	0.73	1.96	60.30%	-28.80%	-25.39%
CAMP	CAMP4 THERAPEUTICS CORP	$246.62M	-162.50%	-101.10%	-78.60%	-1,276.40%	1.47	7.35	100.00%	-2,298.50%	-2,298.54%
ERAS	ERASCA INC	$4.97B	-34.50%	-28.70%	-33.88%	-32.40%	0.22	10.04	N/A	N/A	N/A
AKTS	AKTIS ONCOLOGY INC	N/A	N/A	N/A	N/A	N/A	-0.59	9.27	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$825.02M	N/A	-84.80%	-120.48%	-27.40%	-1.59	1.73	87.10%	-126.30%	-87.45%
ACIU	AC IMMUNE SA	$299.12M	-101.80%	-38.80%	-117.96%	-526.40%	2.44	1.02	100.00%	-1,971.60%	-1,966.30%
SLS	SELLAS LIFE SCIENCES GROUP INC	$951.79M	-63.10%	-54.50%	-37.66%	3,232.60%	0.11	10.72	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$262.49M	-53.80%	-33.90%	-32.17%	-39.60%	0.40	7.81	100.00%	-292.10%	-291.74%
GLPG	GALAPAGOS NV	$2.02B	-16.20%	-11.30%	-14.48%	-14.00%	0.44	8.63	71.10%	-151.40%	-158.11%
ALLO	ALLOGENE THERAPEUTICS INC	$568.00M	-57.10%	-41.60%	-49.51%	-51.20%	0.42	7.93	N/A	N/A	N/A
CDXS	CODEXIS INC	$159.02M	-90.50%	-32.60%	-31.94%	-26.50%	1.93	3.82	86.70%	-62.50%	-55.57%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Veracyte (NASDAQ:VCYT)

Veracyte (NASDAQ:VCYT) is the #1 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Veracyte (NASDAQ:VCYT) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Veracyte (NASDAQ:VCYT) has a Due Diligence Score of 59, which is 34 points higher than the biotech industry average of 25.

VCYT passed 19 out of 33 due diligence checks and has strong fundamentals. Veracyte has seen its stock lose -2.67% over the past year, overperforming other biotech stocks by 32 percentage points.

Veracyte has an average 1 year price target of $45.17, an upside of 37.75% from Veracyte's current stock price of $32.79.

Veracyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Veracyte, 50% have issued a Strong Buy rating, 16.67% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

2. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #2 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 30, which is 5 points higher than the biotech industry average of 25.

PHAR passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 86.1% over the past year, overperforming other biotech stocks by 121 percentage points.

Pharming Group Nv has an average 1 year price target of $39.00, an upside of 140.3% from Pharming Group Nv's current stock price of $16.23.

Pharming Group Nv stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Pharming Group Nv, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #3 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -9 points lower than the biotech industry average of 25. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 39.8% over the past year, overperforming other biotech stocks by 74 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $223.91, an upside of 18.42% from Jazz Pharmaceuticals's current stock price of $189.08.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 281.69%, which is 242 percentage points higher than the biotech industry average of 39.49%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 21.04%, which is -18 percentage points lower than the biotech industry average of 39.49%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.14%, which is -32 percentage points lower than the biotech industry average of 39.49%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.92% in the last day, and up 1.12% over the last week. Sarepta Therapeutics was the among the top gainers in the biotechnology industry, gaining 34.98% yesterday.

Sarepta Therapeutics shares are trading higher after the company announced that early results from Phase 1/2 studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 and SRP-1003 for myotonic dystrophy type 1. Also, the company generated proof-of-concept data for SRP-1001 and SRP-1003.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.37% in the past year. It has overperformed other stocks in the biotech industry by 18 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 48.57% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 13.46% in the past year. It has overperformed other stocks in the biotech industry by 48 percentage points.

Are biotech stocks a good buy now?

63.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.6% over the next year.

2.4% of biotech stocks have a Zen Rating of A (Strong Buy), 4.37% of biotech stocks are rated B (Buy), 47.38% are rated C (Hold), 34.28% are rated D (Sell), and 11.57% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 25.57x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.